Market revenue in 2023 | USD 101.1 million |
Market revenue in 2030 | USD 167.2 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Manual tests |
Fastest growing segment | Automated Instruments |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Automated Instruments, Consumables & Media, Manual Tests |
Key market players worldwide | Bio-Rad Laboratories Inc, Merck & Co Inc, Thermo Fisher Scientific Inc, Danaher Corp, BD, BioMerieux SA, Creative Diagnostics, ElitechGroup, Roche, HiMedia Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antimicrobial susceptibility testing market will help companies and investors design strategic landscapes.
Manual tests was the largest segment with a revenue share of 53.81% in 2023. Horizon Databook has segmented the India antimicrobial susceptibility testing market based on automated instruments, consumables & media, manual tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the India antimicrobial susceptibility testing market, including forecasts for subscribers. This country databook contains high-level insights into India antimicrobial susceptibility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account